BarstisJL, BlackAC. Myelopathy after radiation therapy and chemotherapy with capecitabine and gemcitabine. Cancer Invest2005; 23:596–8.
2.
KwonEJ, KimSW, KimKK. A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome. Cancer Res Treat2009; 41:53–5.
3.
TakahiroMaeda, EijiKikuchi, KazuhiroMatsumoto,. Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient. Int J Clin Oncol2010; 15:508–11.
4.
TatjanaPS, MartinaGS, MartinP. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med2008; 40:665–71.
5.
NaranjoCA, BustoU, SellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30:239–45.
SaitoB, NakamakiT, NakashimaH. Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia. Am J Hematol2007; 82:304–6.
8.
WangMY, ArnoldAC, VintersHV. Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy. Am J Ophthalmol2000; 130:367–8.
9.
TakedaS, YamazakiK, MiyakawaT. Progressive multifocal Ieukoencephalopathy showing extensive spinal cord involvement in a patient with lymphocytopenia. Neuropathology2009; 29:485–93.
